Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE) (OTC: TREIF) (FRA: 939), a healthcare AI technology company, announces that the Company has granted an aggregate 3,052,500 restricted share units (the “RSUs”) to consultants of the Company. The RSUs are valid for a two-year term and are governed by the Company’s RSU Plan, approved by the Company’s Board of Directors on September 21, 2021.
